CA3000584A1 - Analyte detection with multiple substrates - Google Patents

Analyte detection with multiple substrates Download PDF

Info

Publication number
CA3000584A1
CA3000584A1 CA3000584A CA3000584A CA3000584A1 CA 3000584 A1 CA3000584 A1 CA 3000584A1 CA 3000584 A CA3000584 A CA 3000584A CA 3000584 A CA3000584 A CA 3000584A CA 3000584 A1 CA3000584 A1 CA 3000584A1
Authority
CA
Canada
Prior art keywords
agent
bead
analyte
peptide
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3000584A
Other languages
English (en)
French (fr)
Inventor
Antony James Sheehan
Michael Francis Crouch
Original Assignee
TGR Bioscience Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TGR Bioscience Pty Ltd filed Critical TGR Bioscience Pty Ltd
Publication of CA3000584A1 publication Critical patent/CA3000584A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
CA3000584A 2015-10-02 2016-09-30 Analyte detection with multiple substrates Abandoned CA3000584A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562236676P 2015-10-02 2015-10-02
US62/236,676 2015-10-02
US201562237522P 2015-10-05 2015-10-05
US62/237,522 2015-10-05
PCT/IB2016/001981 WO2017068431A1 (en) 2015-10-02 2016-09-30 Analyte detection with multiple substrates

Publications (1)

Publication Number Publication Date
CA3000584A1 true CA3000584A1 (en) 2017-04-27

Family

ID=58446765

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3000584A Abandoned CA3000584A1 (en) 2015-10-02 2016-09-30 Analyte detection with multiple substrates

Country Status (9)

Country Link
US (3) US20180275121A1 (https=)
EP (1) EP3356822B1 (https=)
JP (1) JP2018533017A (https=)
CN (1) CN108603877A (https=)
AU (1) AU2016341539A1 (https=)
CA (1) CA3000584A1 (https=)
HK (1) HK1254374A1 (https=)
MX (1) MX2018004029A (https=)
WO (1) WO2017068431A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057347A1 (en) 2009-11-12 2011-05-19 Tgr Biosciences Pty Ltd Analyte detection
WO2021070218A1 (ja) * 2019-10-07 2021-04-15 ナノティス株式会社 試料中の被検出物質を検出する方法
TWI832129B (zh) * 2020-12-28 2024-02-11 財團法人工業技術研究院 多重分析物的檢測方法
JP2024538620A (ja) * 2021-09-30 2024-10-23 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド 抗ｓａｒｓ－ｃｏｖ－２抗体の二重イムノアッセイのための組成物、キット、および方法
WO2025235476A2 (en) * 2024-05-06 2025-11-13 Beckman Coulter, Inc. Calibration independent immunoassay systems and methods for comparative analyte detection

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006877A1 (en) 1993-09-03 1995-03-09 Behringwerke Ag Fluorescent oxygen channeling immunoassays
WO2003081210A2 (en) * 2002-03-21 2003-10-02 Sunesis Pharmaceuticals, Inc. Identification of kinase inhibitors
US20030232394A1 (en) 2002-06-12 2003-12-18 Aventis Pharma Deutschland Gmbh High throughput screening method and assay system for determining the interaction between C-reactive protein and components binding to it
DE10226011A1 (de) * 2002-06-12 2004-01-08 Aventis Pharma Deutschland Gmbh HTS-fähiges Verfahren und Testsystem zur Ermittlung der Wechselwirkung zwischen c-reaktivem Protein und an C-reaktives Protein bindenden Komponenten
AU2008328726B2 (en) * 2007-11-30 2014-06-12 Glaxo Group Limited Antigen-binding constructs
EP2398868B1 (en) * 2009-02-20 2016-06-15 Perkinelmer Biosignal, Inc. Multiplex assay methods and compositions
JP5770161B2 (ja) * 2009-04-06 2015-08-26 ノヴォ ノルディスク アー／エス 血小板への第ｖｉｉｉ因子タンパク質の標的送達
WO2011057347A1 (en) 2009-11-12 2011-05-19 Tgr Biosciences Pty Ltd Analyte detection
EP3800474B1 (en) * 2011-03-31 2023-11-01 Tgr Biosciences Pty Ltd Detection of multiple analytes
WO2012129610A1 (en) * 2011-03-31 2012-10-04 Tgr Biosciences Pty Ltd One-step immunoassay detection of analytes
GB201403875D0 (en) * 2014-03-05 2014-04-16 Cantargia Ab Novel antibodies and uses thereof
WO2016029220A1 (en) * 2014-08-22 2016-02-25 Nectagen, Inc. Affinity proteins and uses thereof
CN104897652B (zh) * 2015-03-19 2017-08-25 杭州金溪生物技术有限公司 一步均相化学发光法进行小分子检测的方法及所用微粒

Also Published As

Publication number Publication date
HK1254374A1 (zh) 2019-07-19
MX2018004029A (es) 2018-07-06
US20170097339A1 (en) 2017-04-06
EP3356822A1 (en) 2018-08-08
US20180136202A1 (en) 2018-05-17
JP2018533017A (ja) 2018-11-08
US20180275121A1 (en) 2018-09-27
AU2016341539A1 (en) 2018-04-26
EP3356822B1 (en) 2021-10-27
WO2017068431A1 (en) 2017-04-27
EP3356822A4 (en) 2019-07-03
CN108603877A (zh) 2018-09-28

Similar Documents

Publication Publication Date Title
US9476874B2 (en) Analyte detection
AU2003234327B2 (en) Binary or polynary targeting and uses thereof
US20180136202A1 (en) Immunological Testing
EP2021778B1 (en) Nonseparation assay methods
US8900816B2 (en) Assay for anti-EGFRvIII antibodies
US20170138937A1 (en) Detection of analytes
US11802881B2 (en) Saturation binding ratiometric assay
EP3800474B1 (en) Detection of multiple analytes
JPH04223270A (ja) ホスホリル化されたチロシンを含有する蛋白質を検出する方法及び組み合せ試薬
JPH10502171A (ja) 多相系におけるイムノアッセイの実施方法
US8133683B2 (en) Methods for detecting biomolecules in a sample
JP2004053416A (ja) Ｃ末端標識タンパク質を用いるタンパク質−分子間相互作用の解析方法
JP5576585B2 (ja) リン酸化タンパク質免疫測定用試薬
EP2573565A1 (en) Immune detection method for common epitopes of two or more analytes in samples of complex compositions, device, and kit for enabling said immune detection method

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20221222